Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
drugs help end-stage anemic kidney patients - Reuters
Anemia drugs help end-stage anemic kidney patients Reuters CHICAGO (Reuters) - Aggressive treatment with blockbuster drugs may offer the best approach for kidney dialysis patients with severe , ... For Some on Dialysis, Anemia Drugs Pose Risks Anemia Severity Impacts Benefit/Risk Of Amgen ESA Drugs Study of anemia drug outcomes in ESRD patients supports new guidelines |
FDA unveils risk-management plan for Amgen anti- drugs - Los Angeles Times
FDA unveils risk-management plan for Amgen anti-anemia drugs Los Angeles Times Reporting from Washington - Physicians who want to prescribe Amgen Inc.'s anti- drugs for cancer patients will have to register and ... US sets risk plan for Amgen, J&J anemia drugs Summary Box: FDA plan to manage anemia drug risks FDA Tightens Controls on Anemia Drugs |
Boxed warning added to WinRho - HemOncToday
Boxed warning added to WinRho HemOncToday Intravascular hemolysis can lead to serious complications such as clinically comprising and multisystem organ failure including acute respiratory ... FDA Announces New Boxed Warning for WinRho SDF FDA: Boxed Warning Added To Baxter, Cangene Treatment WinRho SDF |
Rockwell Medical Schedules Investor Conference Call - MarketWatch (press release)
Rockwell Medical Schedules Investor Conference Call MarketWatch (press release) SFP is a novel, investigational, continuous iron therapy designed to treat iron deficiency in ESRD patients. SFP is a proprietary, water-soluble form ... |
Rockwell Medical Reports Excellent Fourth Quarter and Full Year 2009 Business ... - MarketWatch (press release)
Rockwell Medical Reports Excellent Fourth Quarter and Full Year 2009 Business ... MarketWatch (press release) SFP is a novel, investigational, continuous iron therapy designed to treat iron deficiency in ESRD patients. SFP is a proprietary, water-soluble form ... Rockwell Medical Reports Excellent Fourth Quarter and Full Year 2009 Business ... Rockwell Medical increases revenue, narrows losses Rockwell Medical Q4 Loss Narrows |
EIA verifier certification program set - Baxter Bulletin
EIA verifier certification program set Baxter Bulletin An Equine Infectious Verifier Certification program is set for 6 pm March 23 at the Baxter County services building in Mountain Home. ... |
Iron Deficiency : Causes and Prevention - TestCountry.com (blog)
Iron Deficiency Anemia: Causes and Prevention TestCountry.com (blog) Iron Deficiency is a condition when the body lacks the iron it needs. Iron is an important mineral that is used by the body in the production of red ... What Parents Should Know About Kids and Supplements |
Affymax receives $5M payment for drug development - The Associated Press
Affymax receives $5M payment for drug development The Associated Press Biotechnology company Affymax Inc. has received a $5 million milestone payment from Takeda Pharmaceutical Co. for the development of a potential ... Affymax(R) Receives $5 Million Milestone Payment on Initiation of Phase 3 ... Takeda makes milestone payment to Affymax over Hematide development |
Piper Jaffray Initiates Coverage on Amgen (AMGN) with a Neutral; ... - StreetInsider.com (subscription)
Piper Jaffray Initiates Coverage on Amgen (AMGN) with a Neutral; Anemia ... StreetInsider.com (subscription) In the interim, we expect Medicare and FDA review of drugs in chronic kidney disease and positive Phase III data for competitor Hematide (Affymax) to ... |
FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection ... - PR Newswire (press release)
FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection ... PR Newswire (press release) People with MDS may experience , neutropenia, and/or thrombocytopenia which can lead to a variety of symptoms including fatigue, shortness of breath, ... Dacogen treatment plan approved Eisai says FDA approved new Dacogen dosing |